# Bank7 Corp.: filings

BSVN · Nasdaq · CIK 1746129 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bsvn.md) · [Financials](/companies/bsvn/financials.md) · [Filings](/companies/bsvn/filings.md) · [Insiders](/companies/bsvn/insiders.md)

## Reports and events: 107 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 283, 8-K 58, 144 25, 10-Q 24, 3 14, CORRESP 9, 10-K 8, DEF 14A 8, 4/A 7, DEFA14A 7, UPLOAD 7, ARS 4, EFFECT 4, SC 13D/A 4, FWP 3, S-3 3, S-3/A 3, 424B4 2, S-1/A 2, S-8 2, SC 13G 2, SC 13G/A 2, 424B3 1, 8-A12B 1, 8-K/A 1, CERT 1, DRS 1, NT 10-K 1, PRE 14A 1, RW 1, S-1 1, S-1MEF 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-15 | 08:00 ET | [8-K](/filings/0001140361-26-039667.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-039667 |
| 2026-10-09 | 15:52 ET | [8-K](/filings/0001140361-26-039264.md) | 8.01 Other events | 0001140361-26-039264 |
| 2026-09-17 | 07:30 ET | [8-K](/filings/0001140361-26-036855.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-036855 |
| 2026-09-10 | 16:30 ET | [8-K](/filings/0001140361-26-036192.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-26-036192 |
| 2026-09-03 | 16:05 ET | [8-K](/filings/0001140361-26-035571.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-035571 |
| 2026-08-10 | 16:16 ET | [10-Q](/filings/0001140361-26-032024.md) | Quarterly report, period 2026-06-30 | 0001140361-26-032024 |
| 2026-07-16 | 08:00 ET | [8-K](/filings/0001140361-26-028609.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-028609 |
| 2026-07-02 | 17:00 ET | [8-K](/filings/0001140361-26-027463.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-027463 |
| 2026-05-21 | 16:36 ET | [8-K](/filings/0001140361-26-022462.md) | 5.07 Shareholder vote results | 0001140361-26-022462 |
| 2026-05-11 | 16:35 ET | [10-Q](/filings/0001140361-26-020594.md) | Quarterly report, period 2026-03-31 | 0001140361-26-020594 |
| 2026-04-14 | 08:00 ET | [8-K](/filings/0001140361-26-014522.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-014522 |
| 2026-04-03 | 09:00 ET | [DEF 14A](/filings/0001140361-26-013116.md) | Proxy statement, period 2026-05-20 | 0001140361-26-013116 |
| 2026-03-17 | 18:03 ET | [10-K](/filings/0001140361-26-009657.md) | Annual report, period 2025-12-31 | 0001140361-26-009657 |
| 2026-01-15 | 08:01 ET | [8-K](/filings/0001140361-26-001264.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-001264 |
| 2025-11-07 | 16:16 ET | [10-Q](/filings/0001140361-25-041162.md) | Quarterly report, period 2025-09-30 | 0001140361-25-041162 |
| 2025-10-15 | 08:00 ET | [8-K](/filings/0001140361-25-038151.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-038151 |
| 2025-08-07 | 16:18 ET | [10-Q](/filings/0001140361-25-029593.md) | Quarterly report, period 2025-06-30 | 0001140361-25-029593 |
| 2025-07-17 | 08:00 ET | [8-K](/filings/0001140361-25-026134.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-026134 |
| 2025-05-19 | 16:15 ET | [8-K](/filings/0001140361-25-019776.md) | 5.07 Shareholder vote results | 0001140361-25-019776 |
| 2025-05-12 | 16:05 ET | [10-Q](/filings/0001140361-25-018373.md) | Quarterly report, period 2025-03-31 | 0001140361-25-018373 |
| 2025-04-10 | 08:00 ET | [8-K](/filings/0001140361-25-013171.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-013171 |
| 2025-04-01 | 16:15 ET | [DEF 14A](/filings/0001140361-25-011616.md) | Proxy statement, period 2025-05-15 | 0001140361-25-011616 |
| 2025-03-25 | 09:00 ET | [8-K](/filings/0001140361-25-010177.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001140361-25-010177 |
| 2025-03-12 | 16:15 ET | [10-K](/filings/0001140361-25-008438.md) | Annual report, period 2024-12-31 | 0001140361-25-008438 |
| 2025-01-16 | 08:00 ET | [8-K](/filings/0001140361-25-001243.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-001243 |
| 2024-11-05 | 09:18 ET | [10-Q](/filings/0001140361-24-045199.md) | Quarterly report, period 2024-09-30 | 0001140361-24-045199 |
| 2024-10-11 | 08:00 ET | [8-K](/filings/0001140361-24-043297.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-043297 |
| 2024-08-08 | 09:30 ET | [10-Q](/filings/0001140361-24-036309.md) | Quarterly report, period 2024-06-30 | 0001140361-24-036309 |
| 2024-07-11 | 08:00 ET | [8-K](/filings/0001140361-24-032886.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-032886 |
| 2024-05-17 | 16:15 ET | [8-K](/filings/0001140361-24-026689.md) | 5.07 Shareholder vote results | 0001140361-24-026689 |
| 2024-05-15 | 09:25 ET | [10-Q](/filings/0001140361-24-026111.md) | Quarterly report, period 2024-03-31 | 0001140361-24-026111 |
| 2024-04-12 | 08:00 ET | [8-K](/filings/0001140361-24-019515.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-019515 |
| 2024-03-28 | 16:09 ET | [DEF 14A](/filings/0001140361-24-016126.md) | Proxy statement, period 2024-05-15 | 0001140361-24-016126 |
| 2024-03-25 | 14:17 ET | [10-K](/filings/0001140361-24-014984.md) | Annual report, period 2023-12-31 | 0001140361-24-014984 |
| 2024-03-20 | 16:05 ET | [8-K](/filings/0001140361-24-014354.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001140361-24-014354 |
| 2024-01-29 | 08:00 ET | [8-K](/filings/0001140361-24-004137.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-004137 |
| 2023-11-09 | 12:07 ET | [10-Q](/filings/0001140361-23-052295.md) | Quarterly report, period 2023-09-30 | 0001140361-23-052295 |
| 2023-10-26 | 08:00 ET | [8-K](/filings/0001140361-23-049593.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-23-049593 |
| 2023-08-09 | 15:04 ET | [10-Q](/filings/0001140361-23-038773.md) | Quarterly report, period 2023-06-30 | 0001140361-23-038773 |
| 2023-07-20 | 09:00 ET | [8-K](/filings/0001140361-23-035324.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-23-035324 |
| 2023-05-22 | 16:15 ET | [8-K](/filings/0001140361-23-025992.md) | 5.07 Shareholder vote results | 0001140361-23-025992 |
| 2023-05-15 | 17:20 ET | [10-Q](/filings/0001140361-23-024806.md) | Quarterly report, period 2023-03-31 | 0001140361-23-024806 |
| 2023-04-27 | 09:00 ET | [8-K](/filings/0001140361-23-020750.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-23-020750 |
| 2023-03-31 | 16:16 ET | [DEF 14A](/filings/0001140361-23-015347.md) | Proxy statement, period 2023-05-18 | 0001140361-23-015347 |
| 2023-03-24 | 16:16 ET | [10-K](/filings/0001140361-23-013727.md) | Annual report, period 2022-12-31 | 0001140361-23-013727 |
| 2023-03-24 | 18:04 ET | [8-K](/filings/0001140361-23-013493.md) | 5.02 Departure or appointment of officers or directors | 0001140361-23-013493 |
| 2023-01-26 | 09:00 ET | [8-K](/filings/0001140361-23-002822.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-23-002822 |
| 2022-11-14 | 16:23 ET | [10-Q](/filings/0001140361-22-041387.md) | Quarterly report, period 2022-09-30 | 0001140361-22-041387 |
| 2022-10-26 | 09:14 ET | [8-K](/filings/0001140361-22-038454.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-22-038454 |
| 2022-08-15 | 16:02 ET | [10-Q](/filings/0001140361-22-029630.md) | Quarterly report, period 2022-06-30 | 0001140361-22-029630 |

Page 1 of 3. [Older](/companies/bsvn/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 2, 2026, 09:01 ET. No prices; not investment advice.